Immunological enhancement by mouse isoantibodies: the importance of complement fixation.

No abstract is available for this paper.

• Publication year

  1968

• Venue

  Immunology

• Publication date

  1968-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 5653816PMCID PMC1409382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ENHANCEMENT OF THE C57BL LEUKEMIA E.L.4 BY FAB FRAGMENTS OF ISOANTIBODY

  1967cited by this paper
• Immunologic enhancement of sarcoma I by mouse gamma-globulin fractions.

  1967cited by this paper
• Transplantation Immunity : Localization in Mouse Serum of Antibodies Responsible for Haemagglutination, Cytotoxicity and Enhancement

  1966cited by this paper
• Capacity of Pepsin-digested Antibody to inhibit Antibody Formation

  1966cited by this paper
• Loss of cytotoxicity of rabbit anti-Ehrlich ascites tumor cell antibody following pepsin digestion.

  1966cited by this paper
• THE REACTION WITH RED CELLS OF 7S RABBIT ANTIBODY, ITS SUB-UNITS AND THEIR RECOMBINANTS.

  1965cited by this paper
• Digestion of anti-kidney antibody: effects on its nephrotoxicity and ability to fix complement.

  1965cited by this paper
• CHANGES IN THE HOST RESPONSE FOLLOWING TREATMENT WITH LYOPHILIZED TISSUE

  1964cited by this paper
• ELECTROPHORETIC SEPARATION AND PROPERTIES OF MOUSE ANTIHAPTEN ANTIBODIES INVOLVED IN PASSIVE CUTANEOUS ANAPHYLAXIS AND PASSIVE HEMOLYSIS

  1964cited by this paper
• THE IMMUNOGLOBULINS OF MICE

  1964cited by this paper
• Immunological enhancement of a leukaemia.

  1962cited by this paper
• QUANTITATIVE STUDIES OF THE SENSITIVITY OF NORMAL AND NEOPLASTIC MOUSE CELLS TO THE CYTOTOXIC ACTION OF ISOANTIBODIES

  1962cited by this paper
• Immune mechanisms in homotransplantation. I. The role of serum antibody and complement in the neutralization of lymphoma cells.

  1960cited by this paper
• Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum.

  1956cited by this paper
• The antibody response to tumor inoculation; improved methods of antibody detection.

  1954cited by this paper
• Regression or survival of tumor homoiografts in mice pretreated with injections of lyophilized tissues.

  1952cited by this paper
• Inhibition and stimulation of tumor homoiotransplants by prior injections of lyophilized tumor tissue.

  1946cited by this paper

• Immunological enhancement revisited.

  2002cites this paper
• Correlation and modulation of Ehrlich ascites tumor growth with tumor-plasma IgA.

  2000cites this paper
• 6 – Immunoregulation: The Search for the Holy Grail

  1997cites this paper
• Tumor growth versus fetal development--similarities and confusions.

  1986cites this paper
• Immune Complexes and Human Cancer

  1985cites this paper
• Immunosuppressor control as a modality of cancer treatment: effect of plasma adsorption with Staphylococcus aureus protein A.

  1985cites this paper
• Immunoglobulin fragments, F(ab')2, that are cytotoxic to enzyme-treated cells.

  1984cites this paper
• In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes.

  1983cites this paper
• Induction of plasminogen activator synthesis by antibodies

  1981cites this paper
• The role of antibody in tumor immunity.

  1981cites this paper
• Abnormal Immunoregulation in Pediatric Cancer and Immunodeficiency

  1981cites this paper
• Role of Antibody Classes in the Regulatory Facilitation Reaction

  1980cites this paper
• Suppression of Rat Renal Allograft Rejection by Antigen and Antibody

  1980cites this paper
• Specificity of antierythrocyte autoantibodies secreted by a NZB-derived hybridoma and NZB peritoneal cells.

  1980cites this paper
• [Main manifestations of immunological disorders in patients with common dermatoses and their pathogenic importance].

  1980cites this paper
• Passive enhancement of mouse tumor allografts by alloantibodies is Fc-dependent.

  1979cites this paper
• Modulation of immunity by antibody, antigen-antibody complexes and antigen.

  1979cites this paper
• The role of purified antibodies and antibody fragments in the enhancement and the acute destruction of mouse allografts

  1979cites this paper
• The suppressor-cell network in cancer (second of two parts).

  1978cites this paper
• Identification and characterization of guinea-pig antibodies that contrasensitize in mice.

  1978cites this paper
• Suppressor cells in neoplastic disease.

  1978cites this paper
• Enhancement of growth of allogeneic mouse tumor by the IgG1 fraction of alloantibody preparations.

  1978cites this paper
• The suppressor-cell network in cancer (second of two parts).

  1978cites this paper
• Tumor-bound immunoglobulins: in situ expressions of humoral immunity.

  1977cites this paper
• Biological Basis:Tumour Associated Antigens, the Immune Machinery, and Its Behaviour Concerning Cancer Cells

  1976cites this paper
• Serotherapy of malignant disease.

  1976cites this paper
• Serotherapy of malignant disease.

  1976cites this paper
• Immunological enhancement of a murine tumor allograft by passive alloantibody IgG and F(ab′)2

  1976cites this paper
• Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.

  1975cites this paper
• Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.

  1975cites this paper
• Biologic properties of transplantation immune sera. IV. Influence of the course of immunization, dilution and complexing to antigen on enhancing activity of Ig classes.

  1975cites this paper
• Formation of plaques by adherent spleen cells from nonimmunized mice, incubated in vitro with the nonadherent fraction of immune allogeneic cells

  1975cites this paper
• Biology of the Mouse Histocompatibility-2 Complex

  1975cites this paper
• Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

  1974cites this paper
• Mechanisms of immunological enhancement.

  1974cites this paper
• Characterization of contrasensitizing antibodies.

  1974cites this paper
• Effects of antigen density and non-complement fixing antibody on cytolysis by alloantisera.

  1974cites this paper
• VARIATION IN THE TYPE OF IMMUNE RESPONSE TO MOUSE HISTOCOMPATIBILITY ANTIGENS AS THE FUNCTION OF THEIR FORM

  1974cites this paper
• Suppression and enhancement of allografted tumour.

  1974cites this paper
• Studies on auto-immune encephalomyelitis in the guinea pig. I. Influence of different immunizations on antibody specificity and biological properties, relation to the incidence of the disease.

  1974cites this paper
• Specificity of antileukemia sera prepared by immunization with leukemia cells admixed with normal antigen-blocking sera.

  1974cites this paper
• Report of Ig Ag, Ig D, Ig G and Ig M secreting plasma cells in cancerous lymph nodes.

  1974cites this paper
• Inhibitory effect of lymphoblast formation by IgG Serum fraction of M.S. patients.

  1973cites this paper
• The Thymus and Immune Surveillance

  1973cites this paper
• RENAL TRANSPLANTATION IN THE INBRED RAT XIX. In Vitro Correlates of Enhancement Induction

  1973cites this paper
• Inhibition of renal allograft rejection. Instances in dogs with specific enchancing immunoglobulin and its proteolytic fragments.

  1973cites this paper
• Studies in vascular permeability. ii. comparative extravasation of different immunoglobulin classes in normal guinea pig skin

  1973cites this paper
• The biological significance of tumor-bound immunoglobulins.

  1973cites this paper
• Role of IgG1 in immunological enhancement--facilitation.

  1973cites this paper
• Humoral responses in tumor immunity: review of experimental findings

  1973cites this paper
• Fate of skin allografts in normal mice injected with antigraft strain globulin in relation to the IgG1 and IgG2 class of the antibodies.

  1973cites this paper
• Immunological tumor enhancement and in vitro cytotoxicity. Further evidence for the involvement of 7S 2a-immunoglobulin.

  1973cites this paper
• Effects of humoral and cellular immune reactions on tumor target cells in vitro their depedence on iso-, allo- or xenogenic origin of lymphocytes and antisera

  1973cites this paper
• IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS

  1972cites this paper
• Immunological enhancement: a study of blocking antibodies.

  1972cites this paper
• Enhancement of Renal Allografts in Rats and Man

  1972cites this paper
• MEASUREMENT OF RAT ANTIBODIES USING A HAEMAGGLUTINATING AUTOANALYZER: A Preliminary Report of the Method

  1972cites this paper
• BIOLOGICAL PROPERTIES OF TRANSPLANTATION IMMUNE SERA: III. RELATIONSHIP BETWEEN TEANSPLANTATION (FACILITATION OR INHIBITION) AND SEROLOGICAL (ANAPHYLAXIS OR CYTOLYSIS) ACTIVITIES

  1972cites this paper
• Immune response in the hamster. VI. Antibody response in polyoma oncogenesis.

  1972cites this paper
• Inhibition der cytotoxischen Aktivität von Meerschweinchenanti-BHK-Antikörpern durch Fab-Fragmente

  1972cites this paper
• F(ab') 2 -like immunoglobulin fragments in urines from patients with systemic lupus erythematosus.

  1972cites this paper
• [Cytotoxic activity of guinea pig antibodies against BHK-cells inhibited by Fab-fragments].

  1972cites this paper
• Immunological factors in nonspecific stimulation of host resistance to syngeneic tumors. A review.

  1971cites this paper
• The Effect of Antiserum Fractions on Ehrlich Ascites Tumour Cells

  1971cites this paper
• The role of blocking antibodies in immunological enhancement.

  1971cites this paper
• Enhancement of rat renal allografts with F(ab')2 fragment of donor-specific antikidney serum.

  1971cites this paper
• The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction.

  1971cites this paper
• Passive immunotherapy of leukemia and other cancer.

  1971cites this paper
• Immunological facilitation, a broadening of the concept of the enhancement phenomenon.

  1971cites this paper
• Actions and Interactions of Immunoglobulins in Immune Tissue Damage

  1971cites this paper
• Immunologic enhancement induced by antibody fragments.

  1970cites this paper
• Tumor-specific humoral antibodies against plasma cell tumors in immunized BALB/c mice.

  1970cites this paper
• RENAL TRANSPLANTATION IN THE INBRED RAT: XIV. Mechanism of the Modified Rejection Produced by Bone Marrow Cell Pretreatment

  1970cites this paper
• Effect of Cell Surface Antigen Density on Immunological Enhancement

  1970cites this paper
• Studies on rabbit lymphocytes in vitro. 13. The induction of blast transformation with the F (ab')2 and Fab fragments of anti-lymphocytic, anti-IgG and anti-allotypic globulins.

  1970cites this paper
• F(ab′)2-like Fragments from Severely Burned Patients provide a New Serum Immunoglobin Component

  1970cites this paper
• Cellular immunity against tumor antigens.

  1969cites this paper
• Graft survival and immunological enhancement.

  1969cites this paper
• Regulation of immunity toward allogeneic tumors in mice. I. Effect of antiserum fractions on tumor growth.

  1969cites this paper
• BIOLOGICAL PROPERTIES OF ANTIBODY CLASSES IN TRANSPLANTATION IMMUNE SERA

  1969cites this paper
• THE RELATIONSHIP BETWEEN HL‐A SPECIFICITY AND A HUMAN SPECIES ANTIGEN

  1969cites this paper
• Studies on cellular immunity and its serum‐mediated inhibition in moloney‐virus‐induced mouse sarcomas

  1969cites this paper
• [Mechanisms common to autoimmune injuries and homograft rejection].

  1969cites this paper
• Immunologic enhancement of tumor xenografts by pepsin-degraded immunoglobulin.

  1969cites this paper
• Enhancing antibody. I. Bioassay for normal skin grafts.

  1969cites this paper
• The use of enhancement in studying tumor antigens.

  1968cites this paper
• lmmunologic Enhancement of Tumor Xenografts by Pepsin-Degraded Immunoglobulin

  1968cites this paper